ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin

NCT00054691 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Skin Cancer

Interventions

DRUG: Iressa

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]